Study finds no clinically useful biomarkers for long COVID in routine lab tests Post author: Post published:August 14, 2024 Post category:uncategorized Whether tests in current use were adequate to identify post-acute sequelae of SARS-CoV-2 (PASC). You Might Also Like Diabetes rates surge 18.6% in the U.S., highlighting racial and economic disparities August 25, 2024 Menopause transition linked to changes in blood cholesterol and cardiovascular risk August 27, 2024 Exploring mouse models for studying liver fibrosis regression November 8, 2024